171 related articles for article (PubMed ID: 35748814)
1. Fast and Sensitive Method for the Determination of 17 Designer Benzodiazepines in Hair by Liquid Chromatography-Tandem Mass Spectrometry.
DeFreitas L; Fonseca Pego AM; Kronstrand R; Lendoiro E; de Castro-Ríos A; Concheiro M
J Anal Toxicol; 2022 Oct; 46(8):852-859. PubMed ID: 35748814
[TBL] [Abstract][Full Text] [Related]
2. Validation of an LC-MS/MS Method for the Quantification of 13 Designer Benzodiazepines in Blood.
Mei V; Concheiro M; Pardi J; Cooper G
J Anal Toxicol; 2019 Oct; 43(9):688-695. PubMed ID: 31436813
[TBL] [Abstract][Full Text] [Related]
3. In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases.
Pettersson Bergstrand M; Richter LHJ; Maurer HH; Wagmann L; Meyer MR
Drug Test Anal; 2019 Jan; 11(1):45-50. PubMed ID: 29996009
[TBL] [Abstract][Full Text] [Related]
4. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
Pettersson Bergstrand M; Helander A; Hansson T; Beck O
Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
[TBL] [Abstract][Full Text] [Related]
5. Recent findings and advancements in the detection of designer benzodiazepines: a brief review.
Wu D; Fu L
Arh Hig Rada Toksikol; 2022; 74(4):224-231. PubMed ID: 38146763
[TBL] [Abstract][Full Text] [Related]
6. The Development and Validation of a Novel Designer Benzodiazepines Panel by LC-MS-MS.
Mastrovito RA; Papsun DM; Logan BK
J Anal Toxicol; 2021 May; 45(5):423-428. PubMed ID: 33476376
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of 75 abuse drugs including amphetamines, benzodiazepines, cocaine, opioids, piperazines, zolpidem and metabolites in human hair samples using liquid chromatography-tandem mass spectrometry.
Shin Y; Kong TY; Cheong JC; Kim JY; Lee JI; Lee HS
Biomed Chromatogr; 2019 Sep; 33(9):e4600. PubMed ID: 31116452
[TBL] [Abstract][Full Text] [Related]
8. Novel and Nonroutine Benzodiazepines and Suvorexant by LC-MS-MS.
Garcia L; Tiscione NB; Yeatman DT; Richards-Waugh L
J Anal Toxicol; 2021 May; 45(5):462-474. PubMed ID: 33988239
[TBL] [Abstract][Full Text] [Related]
9. Urine Drug Screening in the Era of Designer Benzodiazepines: Comparison of Three Immunoassay Platforms, LC-QTOF-MS and LC-MS-MS.
Puzyrenko A; Wang D; Schneider R; Wallace G; Schreiber S; Brandt K; Gunsolus IL
J Anal Toxicol; 2022 Aug; 46(7):712-718. PubMed ID: 34557900
[TBL] [Abstract][Full Text] [Related]
10. Detection and validated quantification of 21 benzodiazepines and 3 "z-drugs" in human hair by LC-MS/MS.
Rust KY; Baumgartner MR; Meggiolaro N; Kraemer T
Forensic Sci Int; 2012 Feb; 215(1-3):64-72. PubMed ID: 21873006
[TBL] [Abstract][Full Text] [Related]
11. Detection of Benzodiazepines and z-Drugs in Hair Using an UHPLC-MS/MS Validated Method: Application to Workplace Drug Testing.
Ramírez Fernández Mdel M; Wille SM; di Fazio V; Kummer N; Hill V; Samyn N
Ther Drug Monit; 2015 Oct; 37(5):600-8. PubMed ID: 25627407
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of an LC-MS-MS Method for the Detection of 40 Benzodiazepines and Three Z-Drugs in Blood and Urine by Solid-Phase Extraction.
Sofalvi S; Lavins ES; Kaspar CK; Michel HM; Mitchell-Mata CL; Huestis MA; Apollonio LG
J Anal Toxicol; 2020 Oct; 44(7):708-717. PubMed ID: 32808043
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous determination of morphine, codeine, 6-acetylmorphine, cocaine and benzoylecgonine in hair by liquid chromatography/electrospray ionization tandem mass spectrometry.
Huang DK; Liu C; Huang MK; Chien CS
Rapid Commun Mass Spectrom; 2009 Apr; 23(7):957-62. PubMed ID: 19241414
[TBL] [Abstract][Full Text] [Related]
14. General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
Broecker S; Herre S; Pragst F
Forensic Sci Int; 2012 May; 218(1-3):68-81. PubMed ID: 22036310
[TBL] [Abstract][Full Text] [Related]
15. Probe Electrospray Ionization Tandem Mass Spectrometry for the Detection and Quantification of Benzodiazepines.
Griffeuille P; El Balkhi S; Dulaurent S; Saint-Marcoux F
Ther Drug Monit; 2024 Mar; ():. PubMed ID: 38498915
[TBL] [Abstract][Full Text] [Related]
16. An analytical strategy for designer benzodiazepines and Z-hypnotics determination in plasma samples using ultra-high performance liquid chromatography/tandem mass spectrometry after microextraction by packed sorbent.
Ares-Fuentes AM; Lorenzo RA; Fernández P; Carro AM
J Pharm Biomed Anal; 2021 Feb; 194():113779. PubMed ID: 33279303
[TBL] [Abstract][Full Text] [Related]
17. Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer.
El Balkhi S; Chaslot M; Picard N; Dulaurent S; Delage M; Mathieu O; Saint-Marcoux F
Int J Legal Med; 2017 Jul; 131(4):979-988. PubMed ID: 28160051
[TBL] [Abstract][Full Text] [Related]
18. Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry.
Pettersson Bergstrand M; Meyer MR; Beck O; Helander A
Drug Test Anal; 2018 Mar; 10(3):496-506. PubMed ID: 28677876
[TBL] [Abstract][Full Text] [Related]
19. A New Multi-Analyte LC-MS-MS Screening Method for the Detection of 120 NPSs and 49 Drugs in Hair.
Rubicondo J; Scuffi L; Pietrosemoli L; Mineo M; Terranova F; Bartucca M; Trignano C; Bertol E; Vaiano F
J Anal Toxicol; 2023 Jan; 46(9):e262-e273. PubMed ID: 36453750
[TBL] [Abstract][Full Text] [Related]
20. Determination of Traditional and Designer Benzodiazepines in Urine through LC-MS/MS.
Rossi B; Freni F; Carelli C; Moretti M; Galatone D; Vignali C; Morini L
Curr Pharm Des; 2022; 28(32):2622-2638. PubMed ID: 36045516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
